Rafał Zieliński (University of Texas, M.D. Anderson Cancer Center in Houston, USA)
Speaker: Rafał Zieliński, PhD (University of Texas, M.D. Anderson Cancer Center in Houston, USA)
Workshop: Grant writing
Time: Monday 15th July, Tuesday 16th July 2013
Venue: Biotechnology Summer School 2013, Intercollegiate Faculty of Biotechnology, Kładki 24
Category: Invited lecture during Biotechnology Summer School
Rafał Zieliński, biographical note
Dr. Rafal Zielinski holds a position at the Department of Experimental Therapeutics, University of Texas, MDAnderson Cancer Center in Houston, TX. He graduated from Catholic University of Lublin, Poland, where he also obtained his PhD. Dr. Zielinski received extensive postdoctoral training at National Institutes of Health, National Cancer Institute, Radiation Oncology Branch, Bethesda MD and Department of Experimental Therapeutics UT, MDAnderson Cancer Center where recently, he was promoted to Research Scientist. His scientific interest is focused on development of new therapies targeting HER2 and oncogenic transcription factors: STAT3, STAT5 and HIF-1a. Dr. Zielinski is an author and co-author of more than twenty peer-reviewed publications. As a Scientist in academic institution, Dr. Zielinski is actively involved in application for research support. His experience involves multiple application for federal (NIH, DOD, SPORE) as well as private foundation grants. Dr. Zielinski also served as reviewer of multiple scientific proposals.